Insulet (NASDAQ:PODD) reported earnings of ($0.03) per share beating Walls Streets expectations.

Insulet (NASDAQ:PODD) reported Q2 2018 earnings this Afternoon, coming in at ($0.03) per share, beating Wall Street’s estimates of ($0.13) per Share. Revenue for the quarter came in at $124.26 million missing the streets estimates of $132.89 million

Recent Insider Trading for Insulet (NASDAQ:PODD)

  • On 6/13/2018 Michael P Spears, SVP, sold 7,496 with an average share price of $100.00 per share and the total transaction amounting to $749,600.00.
  • On 6/1/2018 Shacey Petrovic, Insider, sold 1,067 with an average share price of $94.72 per share and the total transaction amounting to $101,066.24.
  • On 5/30/2018 Michael P. Spears, SVP, sold 8,071 with an average share price of $95.00 per share and the total transaction amounting to $766,745.00.
  • On 5/24/2018 Michael P. Spears, SVP, sold 8,671 with an average share price of $90.00 per share and the total transaction amounting to $780,390.00.
  • On 5/18/2018 Michael P. Spears, SVP, sold 7,774 with an average share price of $87.77 per share and the total transaction amounting to $682,323.98.
  • On 5/15/2018 Michael P. Spears, SVP, sold 8,114 with an average share price of $86.64 per share and the total transaction amounting to $702,996.96.
    Story continues below



    About Company
    Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod Insulin Management System (Omnipod System), which consists of an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of drugs over a specified interval of time, at an administered volume. The company sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.

    Recent Analyst Rating for Insulet (NASDAQ:PODD)



      Recent Trading for Insulet (NASDAQ:PODD)
      Shares of Insulet closed the previous trading session at with shares trading hands.

      An ad to help with our costs